Imax's stock soared 7.23% during intraday trading on Thursday, driven by positive analyst actions that heightened investor optimism.
JPMorgan raised its price target on Imax to $48 from $47 while maintaining an Overweight rating, with reports indicating the company delivered another quarter of strong performance. Other analysts also expressed bullish views on the stock, reinforcing positive sentiment in the market.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments